Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2025-12-26 @ 3:11 AM
Study NCT ID:
NCT00794820
Status:
COMPLETED
Last Update Posted:
2018-05-08
First Post:
2008-11-18
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Fludarabine, Cyclophosphamide, and Rituximab - High Dose Frontline
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-12
Start Date Type:
None
Primary Completion Date:
2014-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-12
Completion Date Type:
ACTUAL
First Submit Date:
2008-11-18
First Submit QC Date:
None
Study First Post Date:
2008-11-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-07-13
Results First Submit QC Date:
None
Results First Post Date:
2016-08-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-04-05
Last Update Post Date:
2018-05-08
Last Update Post Date Type:
ACTUAL